Laser treatment of drusen to prevent progression to advanced age-related macular degeneration (Q24240193)

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Effect of laser treatment for dry age related macular degeneration on foveolar choroidal haemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Long-term effect of laser treatment for dry age-related macular degeneration on choroidal hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic laser treatment appears to promote choroidal neovascularisation in high-risk ARM: results of an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic laser treatment in early age‐related maculopathy: an 8‐year follow‐up in a randomized pilot study shows a reduced incidence of exudative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6 month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Foveal drusen resorption one year after perifoveal laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Self-reported visual functioning and quality of life in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prevalence of age-related macular degeneration in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Prophylactic laser treatment to fellow eyes of unilateral retinal pigment epithelial tears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Influence of laser photocoagulation on choroidal capillary cytoarchitecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Impact of age related macular degeneration on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

The epidemiology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Influence of age-related maculopathy on visual functioning and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Loss of cone function in age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

21 January 2018

Long-term drusen study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Pathophysiology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

Drusen and Disciform Macular Detachment and Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021

Choroidal perfusion abnormality with age-related Bruch's membrane change

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021

Aging changes in Bruch's membrane. A histochemical and morphologic study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021

Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006537.PUB2

7 January 2021